Varnell, Charles Jr. https://orcid.org/0000-0002-0409-3799
Harshman, Lyndsay A.
Liu, Chunyan
Smith, Laurie
Al-Akash, Samhar
Barletta, Gina-Marie
Brakeman, Paul
Chaudhuri, Abanti
Fadakar, Paul
Galea, Lauren
Garro, Rouba
Gluck, Caroline
Kershaw, David B.
Matossian, Debora
Patel, Hiren P.
Peterson, Caitlin
Pruette, Cozumel
Ranabothu, Saritha
Rodig, Nancy
Singer, Pamela
Sebestyen VanSickle, Judith
Weng, Patricia L.
Danziger-Isakov, Lara
Seifert, Michael E.
Hooper, David K.
Funding for this research was provided by:
NIH/NCATS (2KL2TR001426-05A1)
Article History
Received: 8 February 2022
Revised: 30 March 2022
Accepted: 30 March 2022
First Online: 11 May 2022
Declarations
:
: The authors of this manuscript have conflicts of interest to disclose: G.B.—consultant: Alnylam; P.B.—advisory boards: CareDX and Horizon Therapeutics USA, Inc.; J.V.—speaker agreement: Alexion; L.D.—consultant: Merck and Takeda; grant support for contracted clinical research paid to institution: Astellas, Ansun, BioPharma, Merck, Takeda, and Viracor; D.H.—consultant: Hive Networks, Magnolia Innovation, Bioporto, Kaneka, and Alnylam. The other authors declare no competing interests.
Free to read: This content has been made available to all.